ArticleArchives of medical science : AMS2025
Causal associations of circulating inflammatory proteins with sepsis: a two-sample Mendelian randomization study.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sepsis arises from dysregulated inflammation in response to infection, precipitating organ dysfunction. Circulating inflammatory mediators likely contribute to sepsis pathogenesis, but their precise roles remain unclear. We aimed to evaluate potential causal impacts of inflammatory proteins on sepsis risk. Material and methods: We performed a two-sample Mendelian randomization study evaluating causal associations for 91 inflammatory proteins with sepsis risk. Genetic instruments were derived from a published genome-wide association study of plasma proteins. Sepsis outcome data were obtained from the UK Biobank and FinnGen cohort. Inverse-variance weighted analysis was conducted along with several sensitivity analyses. Results: The analyses identified significant causal associations for several inflammatory proteins with sepsis risk. TRAIL exhibited a causal effect on increased overall sepsis risk (OR = 1.10, 95% CI: 1.03-1.17). CCL28 showed a causal link to higher 28-day sepsis mortality in critical care (OR = 3.32, 95% CI: 1.18-9.29). CCL4 demonstrated a causal association with increased 28-day sepsis mortality (OR = 1.81, 95% CI: 1.06-1.31). Meanwhile, beta-NGF was found to be causally protective for sepsis (OR = 0.77, 95% CI: 0.60-0.99), and TNFB also showed a causally protective effect (OR = 0.95, 95% CI: 0.91-1.00). Conclusions: Our study elucidates roles of inflammatory mediators in sepsis pathogenesis. The identified proteins may serve as biomarkers or therapeutic targets. TRAIL signaling inhibition may hold promise for future clinical translation given its causal links to increased sepsis risk and mortality. CCL28 and CCL4 also represent potential immunological drivers of sepsis mortality worthy of further investigation. Meanwhile, the neurotrophins beta-NGF and TNFB emerged as having protective effects in sepsis that could be therapeutically augmented. Further experimental validation is warranted to confirm the observed causal relationships. Our findings provide targets for future mechanistic and clinical examination to impact patient prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.